ArticleEuropean urology open science2025
Validation of Artificial Intelligence-enhanced Stimulated Raman Histopathology for Intraoperative Margin Assessment During Robot-assisted Radical Prostatectomy: Preliminary Results from the ROBOSPEC Study.
Article in European urology open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Intraoperative Techniques Aiding Margin Assessment and Nerve Sparing During Robot-Assisted Radical Prostatectomy.Cancers · 2026Review
- [Between catheters and artificial intelligence: High-tech urology-where manual skills meet digital expertise].Urologie (Heidelberg, Germany) · 2026Review
- Smart Lies and Sharp Eyes: Pragmatic Artificial Intelligence for Cancer Pathology: Promise, Pitfalls, and Access Pathways.Cancers · 2026Review
- Multimodal artificial intelligence in urologic precision oncology: from algorithm to translational medicine (a systemized narrative review).Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: Stimulated Raman histology (SRH) offers promising near-real-time tissue visualization for intraoperative pathology assessment. We present preliminary results from the ROBOSPEC study, with a focus on the accuracy of results obtained via an integrated artificial intelligence (AI) tool. Methods: ROBOSPEC is a prospective, single-arm pilot study involving patients with prostate cancer undergoing robot-assisted radical prostatectomy (RARP). Probes from the RP specimens from the first 18 patients with intermediate-risk or high-risk prostate cancer were collected bilaterally from the dorsolateral sides of the prostate and examined with frozen section with hematoxylin and eosin staining (cryo-HE), SRH imaging (NIO laser imaging system, Invenio Imaging, Santa Clara, CA, USA). A previously published New York University AI algorithm (NYU-AI) that is based on the Inception-ResNet-v2 CNN architecture was used to generate three-color overlays to assist in interpretation. SRH images were reviewed by blinded urologists using this AI-enhanced output. Key findings and limitations: NYU-AI identified positive surgical margins in 22% of patients, with no statistically significant difference in comparison to cryo-HE ( Conclusions and clinical implications: Our preliminary findings support the potential of SRH with NYU-AI for intraoperative detection of positive surgical margins during RARP. Implementation of this technique should be further discussed after more studies have been conducted. Patient summary: We looked at an artificial intelligence program using a method called stimulated Raman histology to assess the cancer status of the cutting margin during robot-assisted surgery to remove the prostate. Our preliminary results show that this method could be an alternative to the current standard as it provides accurate and faster results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.